bioAffinity Technologies, Inc.bioAffinity Technologies, Inc.bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc.

No trades
See on Supercharts
Market capitalization
−0.9032USD
‪−7.94 M‬USD
‪2.53 M‬USD
‪7.45 M‬
Beta (1Y)
6.51

About bioAffinity Technologies, Inc.


CEO
Maria Zannes
Headquarters
San Antonio
Founded
2014
FIGI
BBG018DZJPN8
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Displays a symbol's price movements over previous years to identify recurring trends.